Global Specimen Solutions, Inc. Releases LabCODE™, a GlobalCODE® Ready, State-of-the-Art, Innovative LIMS System

Share Article

Highly innovative LIMS function will expand GlobalCODE® usage into labs and biobanks

LabCODE
We are very excited to bring another innovative solution to the market for our clients to extend their specimen tracking into the laboratory and biobank. The novel LIMS architecture and approach used to build LabCODE™ is another game-changing technological advancement for specimen management.

Global Specimen Solutions, Inc. (http://www.globalspecimensolutions.com) has announced the release of their latest product LabCODE™, a novel Lab Information Management System (LIMS) built for modern laboratory workflows and storage requirements. LabCODE™ offers pre-built capabilities for Biobanking, Pharmacokinetics, Pharmacogenetics, Next Generation Sequencing, Flow Cytometry, Pathology, and much more. LabCODE™ is fully GlobalCODE® ready and can use the predictive analytics of GlobalCODE® to feed the laboratory workflows, then send full data chain-of-custody back to the powerful GlobalCODE® analytic machine.

“We are very excited to bring another innovative solution to the market for our clients to extend their specimen tracking into the laboratory and biobank. The novel LIMS architecture and approach used to build LabCODE™ is another game-changing technological advancement for specimen management. LabCODE™ is fully integrated with the unmatched capabilities of GlobalCODE®, our premiere pipeline data management tool, which has revolutionized live specimen tracking, compliance management, and assay result analytics. With the release of LabCODE™, GlobalCODE® now offers a single solution for clinical trial scientists and laboratory scientists to manage and use powerful integrated data generated internally and externally.”–Amelia Wall Warner, Founder and CEO

Global Specimen Solutions, Inc. offers innovative services combined with fit-for-purpose technology solutions focused on increasing clinical researchers’ ability to make timely, focused and informed decisions that improve the quality of clinical trials and medical research. This groundbreaking approach has forged a new market for tracking and managing real-time pipeline data for the pharmaceutical industry.

“We have been focused, to date, on novel and missing technology approaches in the marketplace. During our growth, we have noticed that while our clients are thrilled with GlobalCODE®, they still are struggling with outdated technology to track local workflows. There have been solutions for LIMS in the marketplace for a long time, but none that use modern design solutions like LabCODE™. This product release expands our portfolio of offerings to span this entire market. We remain committed to building and maintaining the best tools for scientists to allow rapid decision making and informed scientific decisions in real time.”- Pete Tearle, Chief Technology Officer.

Global Specimen Solutions, Inc. has had rapid market uptake in the clinical trial industry, with clients coming from Top 20 pharmaceutical companies to industry leading CROs.

“LabCODE™ was built by industry experts in specimen data flows that recognize the need to innovate faster to match new laboratory platforms and data management needs. By building an end-to-end translational informatics data solution, Global Specimen Solutions is taking its market-leading technology to a new level.”- Gabriel Balint, SVP Software Development.

Global Specimen Solutions continues to lead the market for informed consent, specimen tracking, and assay analytics.

Related Links: http://www.globalspecimensolutions.com

About Global Specimen Solutions, Inc.:
Founded in 2013, Global Specimen Solutions, Inc. is located in Raleigh, NC, where it provides informatics and operational solutions that decrease the time, cost, and risk of human specimen research for the pharmaceutical industry, biotech industry, academia, and other business sectors. The company has built compliant, proprietary processes and tools that rapidly bring capability for precision medicine advancements to its clients.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Scott Clark
@GlobalSpecimen
Follow >
Follow us on
Visit website